Elekta scores its "largest deal ever" in China for cancer solutions
This article was originally published in Clinica
Executive Summary
Swedish cancer therapy specialist Elekta is expecting to pocket $35m in revenue from a public tender it has just won in China to equip the country's military hospitals.